Year |
Citation |
Score |
2011 |
Murnane MJ, Cai J, Shuja S, McAneny D, Willett JB. Active matrix metalloproteinase-2 activity discriminates colonic mucosa, adenomas with and without high-grade dysplasia, and cancers. Human Pathology. 42: 688-701. PMID 21237495 DOI: 10.1016/J.Humpath.2010.08.021 |
0.405 |
|
2009 |
Murnane MJ, Cai J, Shuja S, McAneny D, Klepeis V, Willett JB. Active MMP-2 effectively identifies the presence of colorectal cancer. International Journal of Cancer. Journal International Du Cancer. 125: 2893-902. PMID 19551856 DOI: 10.1002/Ijc.24682 |
0.404 |
|
2000 |
del Re EC, Shuja S, Cai J, Murnane MJ. Alterations in cathepsin H activity and protein patterns in human colorectal carcinomas. British Journal of Cancer. 82: 1317-26. PMID 10755408 DOI: 10.1054/bjoc.1999.1098 |
0.473 |
|
1999 |
Shuja S, Cai J, Iacobuzio-Donahue C, Zacks J, Beazley RM, Kasznica JM, O'Hara CJ, Heimann R, Murnane MJ. Cathepsin B activity and protein levels in thyroid carcinoma, Graves' disease, and multinodular goiters. Thyroid : Official Journal of the American Thyroid Association. 9: 569-77. PMID 10411119 DOI: 10.1089/Thy.1999.9.569 |
0.325 |
|
1998 |
Kim K, Cai J, Shuja S, Kuo T, Murnane MJ. Presence of activated ras correlates with increased cysteine proteinase activities in human colorectal carcinomas. International Journal of Cancer. 79: 324-33. PMID 9699522 DOI: 10.1002/(Sici)1097-0215(19980821)79:4<324::Aid-Ijc4>3.0.Co;2-X |
0.436 |
|
1997 |
Iacobuzio-Donahue CA, Shuja S, Cai J, Peng P, Murnane MJ. Elevations in cathepsin B protein content and enzyme activity occur independently of glycosylation during colorectal tumor progression. The Journal of Biological Chemistry. 272: 29190-9. PMID 9360997 DOI: 10.1074/Jbc.272.46.29190 |
0.457 |
|
1997 |
Murnane MJ, Shuja S, Del Re E, Cai J, Iacobuzio-Donahue C, Klepeis V. Characterizing human colorectal carcinomas by proteolytic profile. In Vivo (Athens, Greece). 11: 209-16. PMID 9239513 |
0.373 |
|
1997 |
Kim K, Kuo T, Cai J, Shuja S, Murnane MJ. N-ras protein: frequent quantitative and qualitative changes occur in human colorectal carcinomas. International Journal of Cancer. 71: 767-75. PMID 9180144 DOI: 10.1002/(Sici)1097-0215(19970529)71:5<767::Aid-Ijc13>3.0.Co;2-5 |
0.391 |
|
1996 |
Shuja S, Murnane MJ. Marked increases in cathepsin B and L activities distinguish papillary carcinoma of the thyroid from normal thyroid or thyroid with non-neoplastic disease. International Journal of Cancer. 66: 420-6. PMID 8635854 DOI: 10.1002/(Sici)1097-0215(19960516)66:4<420::Aid-Ijc2>3.0.Co;2-Y |
0.361 |
|
1995 |
Schroy PC, Brown-Shimer S, Kim K, Johnson KA, Murnane MJ, Yang S, O'Brien MJ, Carney WP, Kupchik HZ. Detection of p21ras mutations in colorectal adenomas and carcinomas by enzyme-linked immunosorbent assay. Cancer. 76: 201-9. PMID 8625092 DOI: 10.1002/1097-0142(19950715)76:2<201::Aid-Cncr2820760207>3.0.Co;2-T |
0.382 |
|
1991 |
Murnane MJ, Sheahan K, Ozdemirli M, Shuja S. Stage-specific increases in cathepsin B messenger RNA content in human colorectal carcinoma. Cancer Research. 51: 1137-42. PMID 1997157 |
0.309 |
|
1991 |
Shuja S, Sheahan K, Murnane MJ. Cysteine endopeptidase activity levels in normal human tissues, colorectal adenomas and carcinomas. International Journal of Cancer. 49: 341-6. PMID 1917131 DOI: 10.1002/Ijc.2910490305 |
0.484 |
|
1989 |
Sheahan K, Shuja S, Murnane MJ. Cysteine protease activities and tumor development in human colorectal carcinoma. Cancer Research. 49: 3809-14. PMID 2544258 |
0.375 |
|
Show low-probability matches. |